期刊文献+

原发性肝癌组织线粒体DNA含量检测及意义 被引量:2

Detection and significance of mitochondrial DNA content in primary liver cancer
下载PDF
导出
摘要 目的检测原发性肝癌及其癌旁组织中线粒体DNA含量,探讨线粒体DNA含量变化与肝癌发生的关系。方法荧光实时定量聚合酶链反应(real-time PCR)法扩增22例肝癌及相应癌旁组织中线粒体DNA编码基因细胞色素C氧化酶Ⅱ(COⅡ),以核编码基因磷酸甘油醛脱氢酶(GAPDH)作为内参照,比较两种组织中线粒体DNA含量的差异。结果肝癌组织中线粒体DNA相对含量为156.54±107.54,癌旁组织线粒体DNA相对含量为290.24±187.37,差异有统计学意义(P<0.01)。结论肝癌组织线粒体DNA的含量与肝癌发生有密切关系,有望成为一种新的肝癌标志物。 Objective To detect mitochondrial DNA content changes within hepatocellular carcinoma(HCC) and paracancer liver tissues. Methods Real-time polymerase chain reaction(PCR) was applied to detect the cytochrome C oxidase Ⅱ (CO Ⅱ ) of mitochondrial DNA in 22 cases of HCC and corresponding paracancer liver tissues, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was served as a quantitative standard marker. Results Mitochondrial DNA content of HCC was 156.54±107.54,which was 290.24±187.37 for corresponding paracancer liver tissues( P〈0.01). Conclusion HCC carcinogenesis is closely correlated with mitochondrial DNA content,and it is hopeful as a new tumor marker.
出处 《临床荟萃》 CAS 2010年第1期33-36,共4页 Clinical Focus
基金 国家科技部"十一五"重大专项基金(2008ZX10001-007) 首都医学发展科研基金(207-2050)
关键词 肝细胞 DNA 线粒体 聚合酶链反应 carcinoma, hepatocellular DNA, mitochondrial polymerase chain reaction
  • 相关文献

参考文献4

二级参考文献40

  • 1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 2Maija H Zile.Abnormal β-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China[J].World Journal of Gastroenterology,2001,7(4):542-546. 被引量:22
  • 3邵建永,李宇红,李晓明,吴秋良,侯景辉,刘宗石.Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas[J].Chinese Medical Journal,2000(9):49-54. 被引量:13
  • 4Nishikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T, Kubo S, Hirohashi K, Kinoshita H, Sato E, Inoue M. Somatic mutation of mitochondrial DNA in carcerous and noncarcerous liver tissue in individuals with hepatocellular carcinoma. Cancer Research, 2001, 61(5):1843~1845.
  • 5Yamamoto H,Tanaka M,Katayama M,Obayashi T,Nimura Y,Ozawa T.Significant existence of deleted mitochondrial DNA in cirrhotic liver surrounding hepatic tumor.Biochem Biophys Res Commun,1992,182:913~920.
  • 6Kotake K,Nonami T,Kurokawa T,Nakao A,Murakami T,Shimomura Y.Human livers with cirrhosis and hepatocellular carcinoma have less mitochondrial DNA deletion than normal human livers.Life Sci,1999,64(19):1785~1791.
  • 7Richter C,Park J W,Ames B N. Normal oxidative damage to mitochondrial and muclear DNAis extensive.Proc Natl Acad Sci USA, 1988, 85 (17): 6465~6477.
  • 8Cadet J,Berger M,Douki T,Morin B,Raoul S,Ravanat J L,Spinelli S.Oxidative damage to DNA: formation, measurement,and biological significance.Rev Physiol Biochem Pharmacol, 1997,131:1~87.
  • 9Richter C.Oxidative damage to mitochondrial DNA and its relationship to ageing.Int J Biochem Cell Biol, 1995,27(7):647~653. Review.
  • 10Nomoto S, Yamashita K, Koshikawa K, Nakao A, Sidransky D.Mitochondrial D-Loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma.Clin Cancer Res, 2002,8(2):481~487.

共引文献21

同被引文献23

  • 1王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:631
  • 2McComsey GA,Leonard E. Metabolic complications of HIV therapy in children[J].{H}AIDS,2004,(13):1753-1768.
  • 3European Paediatric Lipodystrophy Group. Antiretroviral therapy,fat redistribution and hyperlipidaemia in HIV-infected children in Europe[J].{H}AIDS,2004,(10):1443-1451.
  • 4Cossarizza A,Pinti M,Moretti L. Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy[J].{H}Journal of Infectious Diseases,2002,(03):299-305.
  • 5Cōté HC,Brumme ZL,Craib KJ. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients[J].{H}New England Journal of Medicine,2002,(11):811-820.
  • 6Chiappini F,Teicher E,Saffroy R. Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients[J].{H}Laboratory Investigation,2004,(07):908-914.
  • 7Cherry CL,Gahan ME,McArthur JC. Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat[J].{H}Journal of Acquired Immune Deficiency Syndromes,2002,(03):271-277.
  • 8Saitoh A,Fenton T,Alvero C. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy[J].{H}Antimicrobial Agents and Chemotherapy,2007,(12):4236-4242.
  • 9Lewis W,Dalakas MC. Mitochondrial toxicity of antiviral drugs[J].{H}Nature Medicine,1995,(05):417-422.
  • 10Miró O,López S,Martínez E. Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals[J].{H}Clinical Infectious Diseases,2004,(05):710-716.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部